Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma...
Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis
About this item
Full title
Author / Creator
Lai, Tianwen , Wang, Shaobin , Xu, Zhiwei , Zhang, Chao , Zhao, Yun , Hu, Yue , Cao, Chao , Ying, Songmin , Chen, Zhihua , Li, Wen , Wu, Bin and Shen, Huahao
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Currently, limited information is available to clinicians regarding the long-term efficacy of omalizumab treatment for allergic asthma. In this report, we aimed to (i) systematically review the evidence regarding the long-term efficacy of omalizumab in patients with persistent uncontrolled allergic asthma and to (ii) discuss the cost-effectiveness...
Alternative Titles
Full title
Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4314644
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4314644
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/srep08191
